Pier-Luigi Meroni - JoVE Visualize

Showing results (151-160 of 276) with videos related to

Pageof 28

Sort By:

Annals of the Rheumatic Diseases|April 9, 2013

Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosusNicoletta Ronda, Elda Favari, Maria Orietta Borghi, et al.

International Journal of Molecular Sciences|March 13, 2024

Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic VasculopathiesCaterina Bodio, Alessandra Milesi, Paola Adele Lonati, et al.

Advances in Therapy|July 26, 2018

Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED StudyPiercarlo Sarzi-Puttini, Emilio Filippucci, Silvano Adami, et al.

Microorganisms|June 24, 2022

Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 PatientsMassimo Cugno, Pier Luigi Meroni, Dario Consonni, et al.

Arthritis Care & Research|October 4, 2016

Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective AnalysisEnnio Giulio Favalli, Carlo Selmi, Andrea Becciolini, et al.

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|February 26, 2013

Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritisIvana Hollan, Manuela Nebuloni, Barbara Bottazzi, et al.

Clinical Rheumatology|June 10, 2017

Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differencesEnnio Giulio Favalli, Irene Pontikaki, Andrea Becciolini, et al.

Clinical and Experimental Rheumatology|December 2, 2014

Position paper of Italian rheumatologists on the use of biosimilar drugsFabiola Atzeni, Marco Sebastiani, Cristian Ricci, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2020

Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein IPaolo Durigutto, Paolo Macor, Nicola Pozzi, et al.

American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 9, 2013

Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of β(2) glycoprotein INicoletta Di Simone, Silvia D'Ippolito, Riccardo Marana, et al.

Pageof 28

Showing results (151-160 of 276) with videos related to

Sort By:

Pageof 28

Annals of the Rheumatic Diseases|April 9, 2013

Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosusNicoletta Ronda, Elda Favari, Maria Orietta Borghi, et al.

International Journal of Molecular Sciences|March 13, 2024

Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic VasculopathiesCaterina Bodio, Alessandra Milesi, Paola Adele Lonati, et al.

Advances in Therapy|July 26, 2018

Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED StudyPiercarlo Sarzi-Puttini, Emilio Filippucci, Silvano Adami, et al.

Microorganisms|June 24, 2022

Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 PatientsMassimo Cugno, Pier Luigi Meroni, Dario Consonni, et al.

Arthritis Care & Research|October 4, 2016

Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective AnalysisEnnio Giulio Favalli, Carlo Selmi, Andrea Becciolini, et al.

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|February 26, 2013

Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritisIvana Hollan, Manuela Nebuloni, Barbara Bottazzi, et al.

Clinical Rheumatology|June 10, 2017

Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differencesEnnio Giulio Favalli, Irene Pontikaki, Andrea Becciolini, et al.

Clinical and Experimental Rheumatology|December 2, 2014

Position paper of Italian rheumatologists on the use of biosimilar drugsFabiola Atzeni, Marco Sebastiani, Cristian Ricci, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2020

Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein IPaolo Durigutto, Paolo Macor, Nicola Pozzi, et al.

American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 9, 2013

Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of β(2) glycoprotein INicoletta Di Simone, Silvia D'Ippolito, Riccardo Marana, et al.

Pageof 28